Naltrexone Hydrochloride

FRANCOPIA Paris FR

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

Certificate Number

CEP 2009-287 - Rev 03

Status

Valid

Type

Chemical

Issue Date

2024-03-01

End Date

Substance Number

1790

01

FRANCOPIA Paris FR

France

Pharma, Lab & Chemical Expo

Not Confirmed

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

Naltrexone hydrochloride

Certificate Number : CEP 2009-287 - Rev 03

Status : Valid

Issue Date : 2024-03-01

Type : Chemical

Substance Number : 1790

MACFARLAN SMITH LIMITED Edinburgh G...

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Naltrexone hydrochloride

Certificate Number

R1-CEP 2008-058 - Rev 00

Status

Valid

Type

Chemical

Issue Date

2014-09-12

End Date

Substance Number

1790

02

MACFARLAN SMITH LIMITED Edinburgh G...

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Naltrexone hydrochloride

Certificate Number : R1-CEP 2008-058 - Rev 00

Status : Valid

Issue Date : 2014-09-12

Type : Chemical

Substance Number : 1790

RUSAN PHARMA LTD Mumbai IN

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

India

Virtual Booth

Digital Content

Naltrexone hydrochloride

Certificate Number

R1-CEP 2016-053 - Rev 00

Status

Valid

Type

Chemical

Issue Date

2023-01-13

End Date

Substance Number

1790

03

RUSAN PHARMA LTD Mumbai IN

India

CPhI WW Frankfurt

Booth #9.2B82

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

India

Virtual Booth

Digital Content

Naltrexone hydrochloride

Certificate Number : R1-CEP 2016-053 - Rev 00

Status : Valid

Issue Date : 2023-01-13

Type : Chemical

Substance Number : 1790

NORAMCO, LLC. Wilmington US

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Naltrexone hydrochloride, Wavelength site

Certificate Number

CEP 2020-291 - Rev 02

Status

Valid

Type

Chemical

Issue Date

2024-04-23

End Date

Substance Number

1790

04

NORAMCO, LLC. Wilmington US

U.S.A

Pharma, Lab & Chemical Expo

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Naltrexone hydrochloride, Wavelength site

Certificate Number : CEP 2020-291 - Rev 02

Status : Valid

Issue Date : 2024-04-23

Type : Chemical

Substance Number : 1790

SPECGX LLC Webster Groves US

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Ireland

Virtual Booth

Digital Content

Naltrexone hydrochloride

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

CEP 2018-218 - Rev 02

Status

Valid

Type

Chemical

Issue Date

2024-11-20

End Date

Substance Number

1790

05

SPECGX LLC Webster Groves US

Ireland

Pharma, Lab & Chemical Expo

Not Confirmed

S.A.L.A.R.S. S.p.A. Como IT

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Italy

Virtual Booth

Digital Content

Naltrexone hydrochloride

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R1-CEP 2006-117 - Rev 02

Status

Valid

Type

Chemical

Issue Date

2017-05-05

End Date

Substance Number

1790

06

S.A.L.A.R.S. S.p.A. Como IT

Italy

Pharma, Lab & Chemical Expo

Not Confirmed

SANECA PHARMACEUTICALS A.S. Hlohove...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Slovakia

Virtual Booth

Digital Content

Naltrexone hydrochloride

Portfolio PDF

Product Web Link

Certificate Number

CEP 2017-313 - Rev 02

Status

Valid

Type

Chemical

Issue Date

2024-06-12

End Date

Substance Number

1790

07

SANECA PHARMACEUTICALS A.S. Hlohove...

Slovakia

Pharma, Lab & Chemical Expo

Not Confirmed

SIEGFRIED LTD. Zofingen CH

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Switzerland

Virtual Booth

Digital Content

Naltrexone hydrochloride

Portfolio PDF

Product Web Link

Certificate Number

R1-CEP 2009-352 - Rev 03

Status

Valid

Type

Chemical

Issue Date

2023-02-15

End Date

Substance Number

1790

08

SIEGFRIED LTD. Zofingen CH

Switzerland

Pharma, Lab & Chemical Expo

Not Confirmed

NORAMCO, LLC. Wilmington US

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Gabon

Virtual Booth

Digital Content

Naltrexone hydrochloride

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R1-CEP 2012-047 - Rev 01

Status

Withdrawn by Holder

Type

Chemical

Issue Date

2021-01-08

End Date

2022-04-12

Substance Number

1790

09

NORAMCO, LLC. Wilmington US

Gabon

Pharma, Lab & Chemical Expo

Not Confirmed

RUSAN PHARMA LTD Mumbai IN

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Gabon

Virtual Booth

Digital Content

Naltrexone hydrochloride

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Certificate Number

R0-CEP 2008-167 - Rev 00

Status

Withdrawn by EDQM F...

Type

Chemical

Issue Date

2010-01-07

End Date

2012-11-13

Substance Number

1790

10

RUSAN PHARMA LTD Mumbai IN

Gabon

Pharma, Lab & Chemical Expo

Not Confirmed

Naltrexone Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers

9 USDMF

8 CEP/COS

2 EU WC

6 KDMF

44 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers

23 FDA Orange Book

14 Europe

4 Canada

2 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik

1 SPI Pharma

2 Seqens

8 DKSH

4 Faran Shimi Pharmaceutical

9 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

8 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

1 Clariant

18 Corel Pharma Chem

6 DFE Pharma

1 Finar

10 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

35 Kerry

4 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

10 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

1 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Coating Systems & Additives

55 Fillers, Diluents & Binders

42 Controlled & Modified Release

25 Thickeners and Stabilizers

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons